ATOS vs. FCX
ATOS (Atossa Therapeutics, Inc.) and FCX (Freeport-McMoRan Inc.) are both stocks. ATOS operates in Biotechnology (Healthcare), while FCX operates in Copper (Basic Materials). Over the past 10 years, ATOS returned -40.99%/yr vs 21.48%/yr for FCX. At a 0.13 correlation, their price movements are largely independent.
Performance
ATOS vs. FCX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATOS achieves a -46.89% return, which is significantly lower than FCX's 39.74% return. Over the past 10 years, ATOS has underperformed FCX with an annualized return of -40.99%, while FCX has yielded a comparatively higher 21.48% annualized return.
ATOS
- 1D
- -3.09%
- 1M
- -19.80%
- YTD
- -46.89%
- 6M
- -57.57%
- 1Y
- -63.23%
- 3Y*
- -30.69%
- 5Y*
- -41.62%
- 10Y*
- -40.99%
FCX
- 1D
- -1.51%
- 1M
- 27.12%
- YTD
- 39.74%
- 6M
- 59.38%
- 1Y
- 77.59%
- 3Y*
- 25.51%
- 5Y*
- 12.50%
- 10Y*
- 21.48%
ATOS vs. FCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ATOS Atossa Therapeutics, Inc. | -46.89% | -37.51% | 7.28% | 66.51% | -66.97% | 68.42% | -39.49% | 53.92% | -67.31% | -81.56% |
FCX Freeport-McMoRan Inc. | 39.74% | 35.41% | -9.41% | 13.69% | -7.91% | 61.41% | 99.06% | 29.59% | -45.11% | 43.75% |
Correlation
The correlation between ATOS and FCX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Nov 9, 2012 | 0.13 |
Fundamentals
ATOS:
$40.52M
FCX:
$102.00B
ATOS:
-$4.37
FCX:
$1.89
ATOS:
1.33
FCX:
5.23
ATOS:
$0.00
FCX:
$26.42B
ATOS:
-$12.00K
FCX:
$7.35B
ATOS:
-$29.16M
FCX:
$9.59B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATOS vs. FCX — Risk / Return Rank
ATOS
FCX
ATOS vs. FCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atossa Therapeutics, Inc. (ATOS) and Freeport-McMoRan Inc. (FCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ATOS | FCX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.51 | ||
| Sortino ratioReturn per unit of downside risk | -3.25 | ||
| Omega ratioGain probability vs. loss probability | 0.83 | 1.29 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.82 | 3.13 | -3.95 |
| Martin ratioReturn relative to average drawdown | -1.36 | 7.90 | -9.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ATOS | FCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.87 | 1.64 | -2.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.55 | 0.28 | -0.83 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.26 | 0.44 | -0.71 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.30 | 0.16 | -0.46 |
Drawdowns
ATOS vs. FCX - Drawdown Comparison
The maximum ATOS drawdown since its inception was -99.99%, which is greater than FCX's maximum drawdown of -92.52%. Use the drawdown chart below to compare losses from any high point for ATOS and FCX.
Loading charts...
Drawdown Indicators
| ATOS | FCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -92.52% | -7.47% |
Max Drawdown (1Y)Largest decline over 1 year | -77.74% | -24.90% | -52.84% |
Max Drawdown (3Y)Largest decline over 3 years | -87.49% | -46.34% | -41.15% |
Max Drawdown (5Y)Largest decline over 5 years | -96.95% | -51.47% | -45.48% |
Max Drawdown (10Y)Largest decline over 10 years | -99.58% | -72.59% | -26.99% |
Current DrawdownCurrent decline from peak | -99.99% | -1.51% | -98.48% |
Average DrawdownAverage peak-to-trough decline | -93.59% | -39.65% | -53.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.62% | 9.85% | +36.77% |
Volatility
ATOS vs. FCX - Volatility Comparison
The current volatility for Atossa Therapeutics, Inc. (ATOS) is 13.46%, while Freeport-McMoRan Inc. (FCX) has a volatility of 14.37%. This indicates that ATOS experiences smaller price fluctuations and is considered to be less risky than FCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATOS | FCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.46% | 14.37% | -0.91% |
Volatility (6M)Calculated over the trailing 6-month period | 67.76% | 35.63% | +32.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 72.77% | 47.46% | +25.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.10% | 44.84% | +31.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 155.32% | 48.61% | +106.71% |
Dividends
ATOS vs. FCX - Dividend Comparison
ATOS has not paid dividends to shareholders, while FCX's dividend yield for the trailing twelve months is around 0.85%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ATOS Atossa Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FCX Freeport-McMoRan Inc. | 0.85% | 1.18% | 1.58% | 1.41% | 0.99% | 0.54% | 0.19% | 1.52% | 1.45% | 0.00% | 0.00% | 8.46% |
Financials
ATOS vs. FCX - Financials Comparison
This section allows you to compare key financial metrics between Atossa Therapeutics, Inc. and Freeport-McMoRan Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATOS and FCX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FCX has higher volatility (14.37%) compared to ATOS (13.46%). In terms of maximum drawdown, ATOS dropped -99.99% vs FCX's -92.52%.
FCX currently has the higher Sharpe Ratio (1.64 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATOS and FCX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer